LATEST

HOW IT DEVELOPED

1. Merck and Moderna release promising data on cancer vaccine trial npr.org  ·  24.10 00:56
2. The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term. marketwatch.com  ·  23.10 20:58
3. Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% arstechnica.com  ·  23.10 00:12
4. Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report nytimes.com  ·  22.10 22:01
5. Moderna’s stock tumbles after reported leak of data for cancer vaccine marketwatch.com  ·  22.10 20:10

More in this section

Other stories